stockrow
Friday 6 November 2026
Export SPOK’s income statement to Excel — free account
Spok Holdings, Inc.
SPOK Healthcare Health Information Services
Spok Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $139.7 million, up 1.49% from fiscal 2024.
- Revenue
- −2.56%
- EPS
- +190.3%
- Free cash flow
- +61.6%
Quarter to September 2026, against a year earlier
11.81
0.06
+0.51%
Follow SPOK
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
11.60 | 17.07 | 17.58 | 17.13 |
+8 more quarters Free account |
P/S ratio |
1.62 | 1.57 | 1.66 | 1.94 | |
P/FCF ratio |
7.30 | 8.42 | 8.87 | 10.76 | |
P/Operating CF |
16.90 | 33.03 | 92.67 | 23.53 | |
P/B ratio |
1.52 | 1.53 | 1.61 | 1.85 | |
Price to Tangible BV |
4.84 | 5.26 | 5.42 | 5.74 | |
EV/Sales |
1.40 | 1.45 | 1.53 | 1.76 | |
EV/EBITDA |
8.94 | 9.97 | 10.63 | 10.62 | |
EV/Operating CF |
5.66 | 6.91 | 7.18 | 8.49 | |
EV/FCF |
6.30 | 7.77 | 8.20 | 9.76 | |
Quick Ratio |
1.07 | 0.87 | 0.85 | 0.98 | |
Current Ratio |
1.29 | 1.09 | 1.09 | 1.18 | |
Net Debt/EBITDA |
(4.56) | (2.61) | (4.97) | (5.27) | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.66 | 0.67 | 0.69 | 0.66 | |
Operating CF/Net income |
1.34 | 1.57 | 1.23 | 3.93 | |
Capex/Depreciation |
(0.77) | (0.65) | (0.61) | (1.64) | |
Research and Development Expense of Revenue |
9.78% | 9.37% | 10.40% | 8.92% | |
Selling, General and Administrative Expense of Revenue |
31.71% | 31.78% | 36.48% | 35.49% | |
Intangible Assets out of Total Assets |
0.50 | 0.51 | 0.51 | 0.48 | |
Share Based Compensation of Revenue |
5.54% | 3.95% | 4.43% | 3.74% | |
Graham Net Nets |
0.02 | (0.02) | (0.03) | (0.01) | |
Graham Number |
11.86 | 9.51 | 9.73 | 11.11 | |
Earnings Yield |
8.62% | 5.86% | 5.69% | 5.84% | |
Free Cash Flow Yield |
13.71% | 11.87% | 11.28% | 9.29% | |
Revenue per Share |
1.58 | 1.68 | 1.60 | 1.65 | |
Operating CF per Share |
0.62 | 0.31 | 0.12 | 0.56 | |
Capex per Share |
(0.04) | (0.03) | (0.03) | (0.07) | |
Free Cash Flow per Share |
0.59 | 0.28 | 0.09 | 0.49 | |
Cash per Share |
1.44 | 0.79 | 0.82 | 1.23 | |
Shareholders Equity per Share |
6.91 | 6.69 | 6.79 | 7.12 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
6.91 | 6.69 | 6.79 | 7.12 | |
Free Cash Flow |
12.24 | 5.87 | 1.84 | 10.12 | |
Working Capital |
12.90 | 4.33 | 3.78 | 8.78 | |
Capital Expenditures |
(0.74) | (0.61) | (0.60) | (1.40) | |
Net Current Asset Value |
3.42 | (5.11) | (5.71) | (1.85) | |
EV/EBIT |
10.85 | 12.21 | 12.97 | 12.47 | |
Capex to Sales |
0.02 | 0.02 | 0.02 | 0.04 | |
Price to Operating Income |
12.58 | 13.24 | 14.03 | 13.76 | |
| Other line items | |||||
Average Receivables |
21.62 | 24.66 | 20.22 | 22.30 | |
Average Payables |
2.87 | 4.15 | 4.11 | 4.80 | |
Average Assets |
203.99 | 202.14 | 199.18 | 211.61 | |
Average Common Equity |
146.61 | 145.40 | 146.35 | 150.56 |
Columns are period end dates · fundamentals updated 2 Nov 2026